GREMPAL
Grup de Recerca en Malalties Prevalents de l´Aparell Locomotor en Atenció Primària (GREMPAL)

Group leader
fundanet_file_Investigador4053-2
Daniel Martínez Laguna
dmartinezl.bcn.ics@gencat.cat
avatar_grups_recerca.png

Projectes

Group projects

European Non-interventional Post Authorization Safety Study for romosozumab by the EU-ADR Alliance

  • Principal investigators: Talita Duarte Salles, Carlen Reyes Reyes
  • Code: 4R18/149
  • Start year: 2018

Estimating Short-Term and Long-Term Direct Economic Burden Associated with Osteoporotic Fracture

  • Principal investigators: Carlen Reyes Reyes
  • Code: 4R19/076
  • Start year: 2019
  • Funders: IQVIA LTD

Utilization and safety of antidementia treatments: a large longitudinal population-based study in Catalonia

  • Principal investigators: Carlen Reyes Reyes
  • Code: 4R22/071
  • Start year: 2022
  • Funders: Institut d’Investigació en Atenció Primària Jordi Gol i Gurina (IDIAPJGol)

Effects of Angiotensin-converting enzyme Inhibitors and Angiotensin receptor blockers: protocol for a Spanish cohort study using routinely collected electronic health records with validation against the ONTARGET trial

  • Principal investigators: Carlen Reyes Reyes
  • Code: 4R22/131
  • Start year: 2022
  • Funders: London School of Hygiene & Tropical Medicine

Preliminary signal assessment in VigiBase enhanced by longitudinal observational health data: the EHDEN pharmacovigilance use case

  • Principal investigators: Carlen Reyes Reyes
  • Code: 4R22/216
  • Start year: 2022
  • Funders: Institut d’Investigació en Atenció Primària Jordi Gol i Gurina (IDIAPJGol)